Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

DTIC-DOME

DACARBAZINE

Standard Dose
100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DTIC-DOME is listed in Drugs@FDA under application 017575 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DACARBAZINE Form and strength INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAYER HLTHCARE Submission history Latest submission status date: 1998-09-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview DTIC-DOME is listed in Drugs@FDA under application 017575 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DACARBAZINE Form and strength INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAYER HLTHCARE Submission history Latest submission status date: 1998-09-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
DTIC-DOME (DACARBAZINE) | Drug Monograph | MedicHelpline